Thursday, January 3, 2013

Oncogene - Table of Contents alert Volume 32 Issue 1

TABLE OF CONTENTS

Volume 32, Issue 1 (January 2013)

In this issue
Original Articles
Short Communication

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Check out Oncogenesis’s most downloaded article in 2012

MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma Open
E Sonkoly et al propose that miR-203 functions as a ‘bona fide’ tumor suppressor in Basal cell carcinoma, whose suppressed expression contributes to oncogenic transformation via derepression of multiple stemness- and proliferation-related genes, and its overexpression could be of therapeutic value.

Don’t miss out on hot content from Oncogenesis – sign up for Free e-alerts today
 

Original Articles

Top

p53 is activated in response to disruption of the pre-mRNA splicing machinery

N Allende-Vega, S Dayal, U Agarwala, A Sparks, J-C Bourdon and M K Saville

Oncogene 2012 32: 1-14; advance online publication, February 20, 2012; 10.1038/onc.2012.38

Abstract | Full Text

Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer

P-H Su, Y-W Lin, R-L Huang, Y-P Liao, H-Y Lee, H-C Wang, T-K Chao, C-K Chen, M W Y Chan, T-Y Chu, M-H Yu and H-C Lai

Oncogene 2012 32: 15-26; advance online publication, February 13, 2012; 10.1038/onc.2012.29

Abstract | Full Text

Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor

S Yoshikawa, M Kukimoto-Niino, L Parker, N Handa, T Terada, T Fujimoto, Y Terazawa, M Wakiyama, M Sato, S Sano, T Kobayashi, T Tanaka, L Chen, Z-J Liu, B-C Wang, M Shirouzu, S Kawa, K Semba, T Yamamoto and S Yokoyama

Oncogene 2012 32: 27-38; advance online publication, February 20, 2012; 10.1038/onc.2012.21

Abstract | Full Text

Constitutive proteasomal degradation of TWIST-1 in epithelial–ovarian cancer stem cells impacts differentiation and metastatic potential

G Yin, A B Alvero, V Craveiro, J C Holmberg, H-H Fu, M K Montagna, Y Yang, I Chefetz-Menaker, S Nuti, M Rossi, D-A Silasi, T Rutherford and G Mor

Oncogene 2012 32: 39-49; advance online publication, February 20, 2012; 10.1038/onc.2012.33

Abstract | Full Text

Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial–mesenchymal transition (EMT)

I Serrano, P C McDonald, F E Lock and S Dedhar

Oncogene 2012 32: 50-60; advance online publication, February 6, 2012; 10.1038/onc.2012.30

Abstract | Full Text

Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop

J Zhang, Q Sun, Z Zhang, S Ge, Z-G Han and W-T Chen

Oncogene 2012 32: 61-69; advance online publication, February 13, 2012; 10.1038/onc.2012.28

Abstract | Full Text

Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1

Z G Gulzar, J K McKenney and J D Brooks

Oncogene 2012 32: 70-77; advance online publication, February 20, 2012; 10.1038/onc.2012.27

Abstract | Full Text

Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex

J Wu, S-W Lee, X Zhang, F Han, S-Y Kwan, X Yuan, W-L Yang, Y S Jeong, A H Rezaeian, Y Gao, Y-X Zeng and H-K Lin

Oncogene 2012 32: 78-85; advance online publication, February 6, 2012; 10.1038/onc.2012.26

Abstract | Full Text

Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion

J Ferguson, I Arozarena, M Ehrhardt and C Wellbrock

Oncogene 2012 32: 86-96; advance online publication, February 6, 2012; 10.1038/onc.2012.25

Abstract | Full Text

CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor–bone microenvironment

Y Sambandam, K Sundaram, A Liu, K L Kirkwood, W L Ries and S V Reddy

Oncogene 2012 32: 97-105; advance online publication, February 13, 2012; 10.1038/onc.2012.24

Abstract | Full Text

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

S M Wilting, P J F Snijders, W Verlaat, A Jaspers, M A van de Wiel, W N van Wieringen, G A Meijer, G G Kenter, Y Yi, C le Sage, R Agami, C J L M Meijer and R D M Steenbergen

Oncogene 2012 32: 106-116; advance online publication, February 13, 2012; 10.1038/onc.2012.20

Abstract | Full Text

Coordinate regulation of estrogen receptor β degradation by Mdm2 and CREB-binding protein in response to growth signals

M Sanchez, N Picard, K Sauvé and A Tremblay

Oncogene 2012 32: 117-126; advance online publication, February 20, 2012; 10.1038/onc.2012.19

Abstract | Full Text

Short Communication

Top

DNA methylation silences miR-132 in prostate cancer

A Formosa, A M Lena, E K Markert, S Cortelli, R Miano, A Mauriello, N Croce, J Vandesompele, P Mestdagh, E Finazzi-Agrò, A J Levine, G Melino, S Bernardini and E Candi

Oncogene 2012 32: 127-134; advance online publication, February 6, 2012; 10.1038/onc.2012.14

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: